Efficacy of different antifungal drugs as initial treatment for patients with talaromycosis: A systematic review and meta-analysis

Deng, 1988, Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases, Rev Infect Dis, 10, 640, 10.1093/clinids/10.3.640 Jayanetra, 1984, Penicilliosis marneffei in Thailand: report of five human cases, Am J Trop Med Hyg, 33, 637, 10.4269/ajtmh.1984.33.637 Supparatpinyo, 1994, Disseminated Penicillium marneffei infection in southeast Asia, Lancet (London, England), 344, 110, 10.1016/S0140-6736(94)91287-4 Liu, 2013, In vitro antifungal drug susceptibilities of Penicillium marneffei from China, J Infect Chemother, 19, 776, 10.1007/s10156-012-0511-7 Supparatpinyo, 2007, Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients, Am J Trop Med Hyg, 77, 350, 10.4269/ajtmh.2007.77.350 Sirisanthana, 1998, Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients, Clin Infect Dis, 26, 1107, 10.1086/520280 Sekhon, 1993, In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole, Eur J Epidemiol, 9, 553, 10.1007/BF00209535 Supparatpinyo, 1993, Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens, Antimicrob Agents Chem, 37, 2407, 10.1128/AAC.37.11.2407 Masur, 2014, Clin Infect Dis, 58, 1308, 10.1093/cid/ciu094 Le, 2017, A trial of itraconazole or amphotericin B for HIV-associated talaromycosis, The N Engl J Med, 376, 2329, 10.1056/NEJMoa1613306 Su, 2015, Single use of itraconazole has no effect on treatment for Penicillium marneffei with HIV infection, Arch Iran Med, 18, 441 Hu, 2013, Penicillium marneffei infection: an emerging disease in mainland China, Mycopathologia, 175, 57, 10.1007/s11046-012-9577-0 Ranjana, 2002, Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect, 45, 268, 10.1053/jinf.2002.1062 Son, 2014, Penicilliosis and AIDS in Haiphong, Vietnam: evolution and predictive factors of death. Med Mal Infect, 44, 495 Ning, 2018, Accuracy of rapid diagnosis of Talaromyces marneffei: a systematic review and meta-analysis, PloS One, 13, e0195569, 10.1371/journal.pone.0195569 Wu, 2008, Clinical presentations and outcomes of Penicillium marneffei infections: a series from 1994 to 2004, Hong Kong Med J, 14, 103 Li, 2008, A clinical study on 101 AIDS cases complicated with Penicilliosis Marneffei, Chin J Aids Std, 14 Vu Hai, 2010, Penicilliosis in Vietnam: a series of 94 patients, Rev Med Int, 31, 812, 10.1016/j.revmed.2010.07.019 Larsson, 2012, Clinical characteristics and outcome of Penicillium marneffei infection among HIV-infected patients in northern Vietnam, AIDS research and therapy, 9, 24, 10.1186/1742-6405-9-24 Ye, 2016 Chen, 2018, Analysis of epidemiology, clinical characteristics, treatment and outcome of 187 cases of AIDS complicated with Penicilliosis Marneffei, Chin Med Pharm, 8, 17 Qiu, 2019, Determinants of prognosis in Talaromyces marneffei infections with respiratory system lesions, Chin Med J, 132, 1909, 10.1097/CM9.0000000000000345 Minister, 2009 Imwidthaya, 2001, Penicillium marneffei: types and drug susceptibility, Mycopathologia, 149, 109, 10.1023/A:1007245226495 Lei, 2018, Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China, Eur J Clin Microbiol Infect Dis, 37, 1099, 10.1007/s10096-018-3222-x Luo, 2019, In vitro susceptibility of berberine combined with antifungal agents against the yeast form of Talaromyces marneffei, Mycopathologia, 184, 295, 10.1007/s11046-019-00325-y Cao, 2009, In vitro interactions of micafungin with amphotericin B, itraconazole or fluconazole against the pathogenic phase of Penicillium marneffei, J Antimicrob Chemother, 63, 340, 10.1093/jac/dkn494